Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation - Related Studies

Home

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

This study has been completed.

Study NCT00306748. Last updated on February 6, 2008. Information provided by Ironwood Pharmaceuticals, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Constipation

2	More general conditions related to this trial
		Signs and Symptoms
		Signs and Symptoms, Digestive

3	Interventions listed in this trial
		MD-1100 Acetate

4	Sponsors listed in this trial
		Ironwood Pharmaceuticals, Inc.